Naltrexona Destoxican Pentafarma (Naltrexone Hydrochloride)

Naltrexone binds competitively to the mu, kappa and delta opioid receptors in the brain without activating them. By occupying these receptors, it blocks the actions of both naturally occurring endorphins and external opioids, thereby diminishing the reinforcing and pleasurable sensations associated with alcohol and opioid use.

The dosage of Naltrexona Destoxican Pentafarma is determined by the prescribing clinician based on the individual’s medical condition, response to therapy and other factors. Healthcare professionals follow local prescribing guidelines and adjust the regimen as needed; patients should follow the specific instructions provided by their prescriber.

Safety data for naltrexone in pregnancy and lactation are limited. The medication should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To request Naltrexona Destoxican Pentafarma, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naltrexone differs from short‑acting antagonists such as naloxone, which are used for emergency overdose reversal, by providing a longer duration of receptor blockade suitable for maintenance therapy. Compared with other oral agents like acamprosate for alcohol dependence, naltrexone directly blocks opioid receptors, offering a distinct mechanism that can be advantageous for patients with a strong opioid component to their addiction.

The product should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Keep the medication out of reach of children and do not use it after the expiry date printed on the label.

Naltrexona Destoxican Pentafarma is supplied as an oral tablet. The tablet is swallowed whole with a glass of water, typically once daily, unless the prescriber advises a different schedule. It should be taken on an empty stomach or as directed by the treating physician.

The most serious adverse reactions include hepatotoxicity (liver injury), severe depression or emergence of suicidal thoughts, and rare allergic responses such as angioedema or anaphylaxis. Patients should be monitored regularly for liver function abnormalities and changes in mood, and any signs of a severe reaction require immediate medical attention.

Naltrexona Destoxican Pentafarma is contraindicated in individuals with acute hepatitis, severe liver disease, or those currently receiving opioid analgesics, as it can precipitate withdrawal. Patients with known hypersensitivity to naltrexone or any of the tablet excipients should also avoid using this medication.